<\/p>\n
Kidpred-siroop<\/strong> is an oral syrup from Cipla containing prednisolone<\/strong> — a synthetic glucocorticoid with strong anti-inflammatory and immunosuppressive activity. Supplied in a 60 mL bottle of paediatric prednisolone oral syrup<\/strong>; the liquid formulation makes accurate weight-based dosing straightforward in children too young to swallow tablets reliably. Used for short courses in acute asthma exacerbation<\/strong> (1–2 mg\/kg\/day for 3–5 days), croup<\/strong> (1 mg\/kg single oral dose, often combined with nebulised epinephrine), severe allergic reactions and angioedema<\/strong>, eczema flares<\/strong>, and longer courses in nephrotic syndrome<\/strong> (60 mg\/m²\/day in induction, then alternate-day taper) and other paediatric autoimmune disease. Standard paediatric dose: 1–2 mg\/kg\/day<\/strong> in 1–2 divided doses, capped at typical adult equivalents. Always weigh the child before each course; doses must be calculated from current weight.<\/strong> Short courses (< 5–7 days) need no taper; longer courses need supervised taper to prevent adrenal crisis. Repeated or prolonged courses can suppress linear growth<\/strong> — height and weight monitoring at every prescriber review.<\/p>\n<\/div>\n <\/p>\n \ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n Kidpred Syrup is an oral syrup manufactured by Cipla containing prednisolone<\/strong>, a medium-potency synthetic glucocorticoid. The liquid formulation is the standard paediatric presentation: it allows precise milligram dosing for small children and infants, and is much easier to administer than crushed tablets to babies and toddlers.<\/p>\n Kidpred Syrup is Cipla's standard paediatric prednisolone oral liquid — designed for children too young to swallow tablets reliably and where exact weight-based dosing matters. Comes in a 60 mL bottle with a measuring device for accurate dosing. Always confirm the per-mL strength stated on the bottle label before measuring (Indian paediatric prednisolone syrups are typically 5 mg\/5 mL or 15 mg\/5 mL; the same dose volume gives a 3× different drug dose between these two concentrations). Prednisolone has strong anti-inflammatory and immunosuppressive effects across almost every tissue. In paediatric practice it is most commonly used for short courses in acute asthma and croup, single-dose treatment of croup, longer courses in nephrotic syndrome, and selected autoimmune and allergic conditions.<\/p>\n Prednisolone enters cells, binds the intracellular glucocorticoid receptor, and the receptor-drug complex translocates to the nucleus where it alters transcription of hundreds of inflammation-related genes. The result is broad suppression of pro-inflammatory cytokines (IL-1, IL-6, TNF-α), inhibition of phospholipase A&sub2; via lipocortin (cutting off prostaglandin and leukotriene production upstream), reduced capillary permeability, and suppressed lymphocyte and eosinophil function.<\/p>\n Plasma half-life: 2–3 hours; biological (anti-inflammatory) half-life: 12–36 hours. Once-daily morning dosing gives effective day-long anti-inflammatory cover for most paediatric indications, while minimising HPA-axis suppression compared with split or evening dosing.<\/p>\n Onset of clinical effect in acute paediatric inflammatory conditions: noticeable improvement in croup or asthma within 2–4 hours<\/strong> of the first dose; peak anti-inflammatory effect at 4–8 hours. Effect persists for 24–36 hours after dosing.<\/p>\n Kidpred Syrup is used across a wide range of paediatric inflammatory and autoimmune conditions:<\/p>\n Kidpred Syrup is niet<\/strong> appropriate for: simple viral upper respiratory infection, undiagnosed wheeze in infants < 12 months (high risk of viral bronchiolitis where steroids are unhelpful or harmful), or routine eczema management (topical steroids first).<\/p>\n Paediatric dosing is weight-based<\/strong>; always weigh the child before each course and re-weigh for any course longer than 1 month. The strength of prednisolone in syrup varies between manufacturers (commonly 5 mg\/5 mL or 15 mg\/5 mL) — always confirm the per-mL strength on the bottle label before measuring the dose<\/strong>.<\/p>\nWaarom bestellen bij MedsBase<\/h3>\n
What Is Kidpred Syrup?<\/h2>\n
How Does Kidpred Syrup Work?<\/h2>\n
Toepassingen en Indicaties<\/h2>\n
\n
Kidpred Syrup Dosage and How to Give to a Child<\/h2>\n
Standard paediatric doses by indication<\/h3>\n